Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 3, 2021
- Accession no.
- 0001447362-21-000182
- Filed
- Aug 3, 2021
- Trade date
- Jul 30-Aug 2, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $244.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Common Stock | SSaleDisposed | −703 | $70.17F2 | −$49,329.51 | 153,257 | Indirect | |
| Jul 30, 2021 | Common Stock | SSaleDisposed | −704 | $70.17F2 | −$49,399.68 | 176,096 | Indirect | |
| Jul 30, 2021 | Common Stock | SSaleDisposed | −704 | $70.17F2 | −$49,399.68 | 163,496 | Indirect | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −456 | $70.26F6 | −$32,038.56 | 152,801 | Indirect | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −456 | $70.26F6 | −$32,038.56 | 175,640 | Indirect | |
| Aug 2, 2021 | Common Stock | SSaleDisposed | −457 | $70.26F6 | −$32,108.82 | 163,039 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
These transactions were executed in multiple trades at prices ranging from $70.03 to $70.56, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
These transactions were executed in multiple trades at prices ranging from $70.00 to $70.64, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.